Skip to main content

Web Exclusives

Lung Cancer, FDA Updates
FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation
Read More
Ovarian Cancer
Zejula Receives New Indication as Maintenance Treatment for Patients with Advanced Ovarian Cancer
Read More
Ovarian Cancer
Improving Patient Access to Biologics: Q&A with Melissa Paige (Part 2 of 2)
Read More
Ovarian Cancer
CMS Covers Telehealth During Emergency Declaration
Read More
Ovarian Cancer
Remote Patient Monitoring Is on the Upswing, with Promising Outcomes Data
Read More
Ovarian Cancer
Ovarian Cancer Remains Deadly, Rates Declining Slowly
Read More
COVID-19
Economic Impact of the COVID-19 Crisis
Read More
COVID-19
Actuarial View of COVID-19: Payers, Providers, and Healthcare Reform
Read More
Lung Cancer, FDA Updates
Opdivo plus Yervoy and Chemotherapy Approved as First-Line Therapy for Metastatic NSCLC, Regardless of PD-L1 Expression
Read More
Hepatocellular Carcinoma, FDA Updates
Tecentriq plus Avastin First Immunotherapy Regimen Approved for Metastatic Hepatocellular Carcinoma
Read More
Page 14 of 43
Results 131 - 140 of 430